NADAC acquisition cost data for ARTHRITIS PAIN ER 650 MG TAB. This is a generic medication, typically more affordable than brand-name equivalents.
| Generic Name | Diclofenac sodium |
| Brand Name | Arthritis Pain Reliever |
| Manufacturer | CVS PHARMACY, INC |
| Dosage Form | GEL |
| Route | TOPICAL |
| Pharmacologic Class | Nonsteroidal Anti-inflammatory Drug |
| Product Type | HUMAN OTC DRUG |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 50268005211 | $0.0699 | 2022-12-21 | OTC |
| 50268005215 | $0.0699 | 2022-12-21 | OTC |
| 50268005211 | $0.0699 | 2022-12-21 | OTC |
| 50268005215 | $0.0699 | 2022-12-21 | OTC |
Generic: Diclofenac Sodium | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $11.1M | 172,662 | 67,350 | $1.27 |
| 2020 | $13.1M | 174,050 | 59,935 | $1.47 |
| 2021 | $11.7M | 169,159 | 59,686 | $1.37 |
| 2022 | $14.8M | 172,338 | 59,804 | $1.48 |
| 2023 | $10.9M | 169,845 | 59,234 | $1.24 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.